Jan Nyman
Sahlgrenska University Hospital · 151 works · 6,533 citations · h-index 40
Top works
- Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy
- Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—Mature results for medically inoperable patients
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
- Prognostic factors for acute and late skin reactions in radiotheraphy patients
- Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries
- Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity
- SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC
- Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: A dose– and volume–response analysis
- Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study
- Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer
- Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer — a randomized study
- The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules
- The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy
- Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial
- Prognostic Factors for Local Control and Survival of Cancer of the Oral Tongue a retrospective analysis of 230 cases in Western Sweden
- Normal tissue radiosensitivity — How important is it?
- A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy
- Does the interval between fractions matter in the range of 4–8 h in radiotherapy? A study of acute and late human skin reactions
- Describing patients' normal tissue reactions: Concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity
- DNA double strand break quantification in skin biopsies